As of August 28, 2026, Nasus Pharma Ltd. (NSRX) has a DilutionWatch DilutionScore of 59/100, rated HIGH dilution risk. Nasus Pharma Ltd. has a market capitalization of $39.35M, 9.02M shares outstanding, 9 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise
model 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split
model est. 15%
• Only 3 months cash — financial pressure
Market Data
Market Cap$39.35M
Shares Outstanding9.02M
Float4.86M
Cash$1.24M
Debt$118.0K
Short InterestN/A
Institutional Holdings
9 institutional holders · 2.18M shares
#1
Balyasny Asset Management L.P.
898.5K shares
#2
Cable Car Capital, LP
602.0K shares
#3
Velan Capital Investment Management LP
359.4K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest160.1K
Days to Cover15.2
% of Float3.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual NSRX Dilution Snapshot
Nasus Pharma Ltd. (NSRX) has a DilutionScore of 59/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for NSRX: xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track NSRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NSRX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for NSRX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.